Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults

Author:

Margraf Alissa M1,Davoodi Natalie M2ORCID,Chen Kevin3,Shield Renee R4,McAuliffe Laura M1,Collins Christine M1,Zullo Andrew R56

Affiliation:

1. Department of Pharmacy, Rhode Island Hospital and Lifespan Corporation , Providence, RI , USA

2. Brown University School of Public Health , Providence, RI , USA

3. The Warren Alpert Medical School of Brown University , Providence, RI , USA

4. Department of Health Services, Policy, and Practice, Brown University School of Public Health , Providence, RI , USA

5. Department of Pharmacy, Rhode Island Hospital , Providence, RI

6. Departments of Epidemiology, Health Services, Policy, and Practice, Brown University School of Public Health , Providence, RI , USA

Abstract

Abstract Purpose Opportunities exist to meaningfully reduce suboptimal prescription opioid use among older adults. Deprescribing is one possible approach to reducing suboptimal use. Appropriate interventions should outline how to carefully taper opioids, closely monitor adverse events, substitute viable alternative and affordable nonopioid pain treatments, and initiate medications for opioid use disorder to properly manage use disorders, as needed. We sought to document and understand provider perceptions to begin developing effective and safe opioid deprescribing interventions. Methods We conducted 3 semistructured focus groups that covered topics such as participant perspectives on opioid deprescribing in older adults, how to design an ideal intervention, and how to identify potential barriers or facilitators in implementing an intervention. Focus group transcripts were double coded and qualitatively analyzed to identify overarching themes. Results Healthcare providers (n = 17), including physicians, pharmacists, nurses, social workers, and administrative staff, participated in 3 focus groups. We identified 4 key themes: (1) involve pharmacists in deprescribing and empower them as leaders of an opioid deprescribing service; (2) ensure tight integration and close collaboration throughout the deprescribing process from the inpatient to outpatient settings; (3) more expansive inclusion criteria than age alone; and (4) provision of access to alternative pharmacological and nonpharmacological pain management modalities to patients. Conclusion Our findings, which highlight various healthcare provider beliefs about opioid deprescribing interventions, are expected to serve as a framework for other organizations to develop and implement interventions. Future studies should incorporate patients’ and family caregivers’ perspectives.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference38 articles.

1. The burden of opioid-related mortality in the United States;Gomes;JAMA Netw Open,2018

2. Opioid use disorder among hospitalized older adults: prevalence, characteristics, and discharge status;Zullo;J Am Med Dir Assoc,2020

3. Deprescribing: what is it and what does the evidence tell us?;Thompson;Can J Hosp Pharm,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3